Literature DB >> 7211896

Infection surveillance and control in the severely traumatized patient.

E S Caplan, N Hoyt.   

Abstract

Among severely traumatized patients, infection is second only to head trauma as the leading cause of death. Few studies have defined the infections that occur, the risk factors involved, or the appropriate means of evaluating these patients. In our trauma unit, daily infection surveillance included clinical evaluation of every patient and all microbiologic data. In addition, prophylactic and therapeutic antibiotics were directly under our control. Over a two period 2,368 patients were admitted, most arriving directly from the scene by patients were admitted, most arriving directly from the scene by helicopter. The over-all mortality was 20 percent. In this setting, 639 nosocomial infections occurred in 381 patients of whom 14 percent died of their infection. Sites of infection in percent of total and of bacteremia (given in parentheses) were urinary tract 18 (3), pneumonia 15 (19), empyema 11 (11), phlebitis 12 (17), primary bacteremia 10 (21), surgical wound 19 (8), intraabdominal 8 (11), CNS 7 (5), sinusitis 5 (0), arterial lines 2 (4) and other 3 (1). Over-all 44 percent of infections were bacteremia. Organisms involved in nosocomial infections as percent of total and in bacteremias given in parentheses) were coagulase-positive Staphylococcus 24 (39), other gram-positive cocci 13 (8), Escherichia coli 13 (9), Proteus 4 (5), anaerobes 3 (1) and other organisms 12 (8). Most infections were directly related to an invasive procedure.

Entities:  

Mesh:

Year:  1981        PMID: 7211896     DOI: 10.1016/0002-9343(81)90587-8

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  12 in total

1.  Sequential epidemic outbreaks of septicaemias by Serratia and Klebsiella species on a medical intensive care unit.

Authors:  J L Cortés; E Domínguez-de Villota; A Algora-Weber; C Chamorro; M C Torrecilla; J M Mosquera
Journal:  Intensive Care Med       Date:  1988       Impact factor: 17.440

Review 2.  Selective decontamination in intensive care practice: a review of clinical experience.

Authors:  G Ramsay; J J Reidy
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

3.  Prevention of colonization and respiratory infections in long-term ventilated patients by local antimicrobial prophylaxis.

Authors:  K Unertl; G Ruckdeschel; H K Selbmann; U Jensen; H Forst; F P Lenhart; K Peter
Journal:  Intensive Care Med       Date:  1987       Impact factor: 17.440

4.  Surgical site infection in abdominal trauma patients: risk prediction and performance of the NNIS and SENIC indexes.

Authors:  Carlos H Morales; Rene M Escobar; Maria I Villegas; Andrés Castaño; Juliana Trujillo
Journal:  Can J Surg       Date:  2011-02       Impact factor: 2.089

5.  Blunt abdominal trauma. A 5-year analysis of 870 patients requiring celiotomy.

Authors:  E F Cox
Journal:  Ann Surg       Date:  1984-04       Impact factor: 12.969

6.  Noninvasive ventilation for patients near the end of life: what do we know and what do we need to know?

Authors:  William J Ehlenbach; J Randall Curtis
Journal:  Crit Care Med       Date:  2008-03       Impact factor: 7.598

7.  Evaluation of antibiotic therapy following penetrating abdominal trauma.

Authors:  R C Jones; E R Thal; N A Johnson; L N Gollihar
Journal:  Ann Surg       Date:  1985-05       Impact factor: 12.969

Review 8.  Risk factors for infection in the trauma patient.

Authors:  A S Morgan
Journal:  J Natl Med Assoc       Date:  1992-12       Impact factor: 1.798

9.  Hospital acquired infections surveillance and control in intensive care services. Results of an incidence study.

Authors:  M Costantini; P M Donisi; M G Turrin; L Diana
Journal:  Eur J Epidemiol       Date:  1987-12       Impact factor: 8.082

10.  Profile of micro-organisms in intensive care unit of a level-1 trauma centre: A retrospective study.

Authors:  Shefali K Sharma; Vijay Hadda; Purvi Mathur; Vinay Gulati; Chhavi Sahney
Journal:  Indian J Crit Care Med       Date:  2013-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.